AI Hedge Fund Sentient Is Said to Shut After Less Than Two Years

AI Hedge Fund Sentient Is Said to Shut After Less Than Two Years

  • September 9, 2018
Table of Contents

AI Hedge Fund Sentient Is Said to Shut After Less Than Two Years

The fledgling world of AI hedge funds is claiming one of its first casualties. Sentient Investment Management is notifying investors of plans to liquidate the hedge fund it started in late 2016, according to people with knowledge of the situation. The fund managed less than $100 million and hasn’t made money this year after gaining 4 percent in 2017, one of the people said.

Sentient, based in San Francisco, used artificial intelligence techniques, including machine learning and so-called evolutionary algorithms, to trade stocks globally. It followed a market-neutral strategy in which bets on rising prices were matched by wagers on falling ones.

Source: bloomberg.com

Tags :
Share :
comments powered by Disqus

Related Posts

Foundations Machine Learning

Foundations Machine Learning

Bloomberg presents ‘Foundations of Machine Learning,’ a training course that was initially delivered internally to the company’s software engineers as part of its ‘Machine Learning EDU’ initiative. This course covers a wide variety of topics in machine learning and statistical modeling. The primary goal of the class is to help participants gain a deep understanding of the concepts, techniques and mathematical frameworks used by experts in machine learning.

Read More
Neural scene representation and rendering

Neural scene representation and rendering

There is more than meets the eye when it comes to how we understand a visual scene: our brains draw on prior knowledge to reason and to make inferences that go far beyond the patterns of light that hit our retinas. For example, when entering a room for the first time, you instantly recognise the items it contains and where they are positioned. If you see three legs of a table, you will infer that there is probably a fourth leg with the same shape and colour hidden from view.

Read More
AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More